Potential savings from biosimilars in Canada = Économies potentielles associées aux biosimilaires au Canada.: H82-34/2017-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.872231&sl=0

Publication information
Department/Agency Canada. Patented Medicine Prices Review Board.
Title Potential savings from biosimilars in Canada = Économies potentielles associées aux biosimilaires au Canada.
Variant title Économies potentielles associées aux biosimilaires au Canada
Publication type Monograph
Language Bilingual-[English | French]
Format Electronic
Electronic document
Note(s) "NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada."
Issued also in HTML format.
Includes bibliographical references.
Text in English and in French.
Publishing information [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2017]
Description 1 online resource (1 page) : coloured graphs
Catalogue number
  • H82-34/2017-PDF
Subject terms Prescription drugs
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Report a problem or mistake on this page
Date modified: